# Diagnostic Value of Magnetic Resonance Susceptibility-Weighted Imaging Scanning in Different Types of Early Prostate Cancer.

> **Reliability concern:** This paper was retracted on 2023-06-21. See notice: 10.1155/2023/9809430.

- **DOI:** [10.1155/2022/4884646](https://doi.org/10.1155/2022/4884646)
- **Rating:** Very Limited (1.1 out of 5)
- **Verdict:** Correlational imaging observations in PSA-stratified prostate cancer patients, fatally undermined by paper mill indicators and absent diagnostic accuracy data.
- **Framework version:** v5.0
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-06-01
- **Evaluation page:** https://www.nabu.science/paper/10.1155%2F2022%2F4884646

## Strengths

- **Addresses a clinically relevant diagnostic question** Prostate cancer diagnosis and early differentiation is a genuine clinical need with identifiable stakeholders including radiologists and urologists. The study targets a problem of real clinical significance.
  - Dimension: application pathway
  - Location: §1
- **Biologically coherent discussion of SWI rationale** The discussion section provides a plausible mechanistic explanation for why SWI-related parameters (microvessel density, deoxyhemoglobin, magnetic susceptibility) would differ between malignant and benign prostate tissue.
  - Dimension: contribution
  - Location: §4.3
- **Defined imaging protocol with scanner specifications** The methods section specifies the MRI scanner model, sequence parameters (TR, TE, matrix, FOV), contrast agent protocol, and SUSE scoring criteria, providing at least a formal methodological framework.
  - Dimension: methodological rigour
  - Location: §3.2

## Limitations

- **Paper mill indicators and impossible statistics** The manuscript contains '[Journal]' placeholder strings throughout, refers to 'leukemia patients' in the abstract of a prostate cancer study, and reports a mathematically impossible control group age range (60–66 years, mean 50.2±5.4). These collectively suggest serious problems with manuscript integrity.
  - Dimension: methodological rigour
  - Location: §Abstract, §3.1, §3.2
- **No diagnostic accuracy metrics despite diagnostic claims** Despite claiming to assess 'diagnostic value,' the paper reports no sensitivity, specificity, PPV, NPV, AUC, or any standard diagnostic performance metric. The findings are limited to group comparisons of imaging parameters across PSA levels.
  - Dimension: contribution
  - Location: §4.1, §4.2, §5
- **Missing ethics approval and conduct safeguards** No ethics approval or institutional review board statement is present for a study involving human subjects undergoing MRI with intravenous contrast agent administration. No conflict of interest disclosure is provided.
  - Dimension: methodological rigour
  - Location: Full text — absent

## Reliability checks

Concerns (4 of 4 checks).

- **Internal coherence:** Concern. The paper contains multiple severe internal inconsistencies: the abstract refers to 'leukemia patients' in a prostate cancer study, PSA groupings differ between abstract and methods, a mathematically impossible age range is reported for the control group, '[Journal]' placeholder strings appear throughout, and PSA units are consistently wrong. These collectively indicate fundamental problems with manuscript integrity.
- **Research conduct:** Concern. No ethics approval or IRB statement is present despite the study involving human subjects undergoing MRI with contrast agent administration. No conflict of interest statement is provided. Data availability is claimed only upon request with no verifiable repository.
- **Reference integrity:** Clean. All 27 cited references resolved to real publications via PubMed, Crossref, or OpenAlex.
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Concern
- **Summary:** This paper was retracted on 2023-06-21. See notice: 10.1155/2023/9809430.
- **Last checked:** 2026-10-17
